GLAXO

Glaxosmithkline Pharma Lt · ISIN INE159A01016 · Health Technology

Margin Trading Facility book for GLAXO across NSE and BSE. Free to use — no signup, no paywall. All figures in ₹ crore, derived from NSE and BSE public disclosures.

Funded value
₹39 Cr
as of 22 Jan 2025
Rank in book
#450
16 days tracked
Share of book
0.05%
of the whole NSE + BSE book
Peak funded
₹44 Cr
on 03 Jan 2025
NSE
₹39 Cr
BSE
₹0 Cr
Largest single-day addition
+₹1 Cr
on 03 Jan 2025
Largest single-day unwind
−₹2 Cr
on 21 Jan 2025

GLAXO — last 16 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole market book, and rank. Newest first.
DateCombinedDay ΔNSEBSE% of bookRank
22 Jan 2025₹39 Cr+₹0₹39₹00.05%450
21 Jan 2025₹39 Cr−₹2₹39₹00.05%452
20 Jan 2025₹42 Cr−₹0₹42₹00.05%427
17 Jan 2025₹42 Cr+₹0₹42₹00.05%422
16 Jan 2025₹42 Cr−₹0₹42₹00.00%422
15 Jan 2025₹42 Cr+₹0₹42₹00.05%416
14 Jan 2025₹42 Cr+₹0₹42₹00.05%416
13 Jan 2025₹42 Cr−₹0₹42₹00.05%418
10 Jan 2025₹42 Cr−₹0₹42₹00.05%423
09 Jan 2025₹42 Cr+₹0₹42₹00.05%427
08 Jan 2025₹42 Cr+₹0₹42₹00.05%433
07 Jan 2025₹42 Cr−₹0₹42₹00.05%433
06 Jan 2025₹42 Cr−₹2₹42₹00.00%434
03 Jan 2025₹44 Cr+₹1₹44₹00.05%423
02 Jan 2025₹43 Cr−₹0₹43₹00.05%422
01 Jan 2025₹43 Cr₹43₹00.05%417

IndiaMTF is an independent informational project. It is not a brokerage, is not affiliated with NSE, BSE or any SEBI-registered entity, and does not provide investment advice. Figures are derived from NSE and BSE public disclosures and may be revised or restated by the exchanges. Verify against the primary source before acting on anything here.